Approval · Notice of Compliance 8374 · 2006
ALDACTONE: Notice of Compliance 8374
Issued October 31, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8374
- Date
- October 31, 2006
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update and new product monograph format
- Therapeutic class
- Aldosterone antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALDACTONE | Not yet assigned | — |
Medicinal ingredients
- SPIRONOLACTONE 25 MG per TAB
- SPIRONOLACTONE 100 MG per TAB